Invention Grant
US08362015B2 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
有权
氨基酰基前药衍生物和治疗血栓栓塞障碍的药物
- Patent Title: Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
- Patent Title (中): 氨基酰基前药衍生物和治疗血栓栓塞障碍的药物
-
Application No.: US12438097Application Date: 2007-08-23
-
Publication No.: US08362015B2Publication Date: 2013-01-29
- Inventor: Hans-Georg Lerchen , Ursula Krenz , Karl-Heinz Schlemmer , Elisabeth Perzborn
- Applicant: Hans-Georg Lerchen , Ursula Krenz , Karl-Heinz Schlemmer , Elisabeth Perzborn
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Agent Karen B. King; Thomas C. Blankinship
- Priority: DE102006039589 20060824
- International Application: PCT/EP2007/007408 WO 20070823
- International Announcement: WO2008/022786 WO 20080228
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/14
Abstract:
The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.
Public/Granted literature
- US20100292230A1 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders Public/Granted day:2010-11-18
Information query
